刺
免疫系统
癌症免疫疗法
干扰素基因刺激剂
化学
癌细胞
兴奋剂
连接器
纳米颗粒
免疫疗法
生物物理学
癌症研究
癌症
细胞生物学
纳米技术
生物化学
材料科学
受体
生物
医学
免疫学
先天免疫系统
内科学
工程类
航空航天工程
计算机科学
操作系统
作者
Pere Dosta,Alexander M. Cryer,Michelle Z. Dion,Tsubasa Shiraishi,Steven Langston,David P. P. Lok,Jianing Wang,Sean Harrison,Tiquella Hatten,Michelle L. Ganno,Vicky A. Appleman,Gonzalo Muñoz Taboada,Núria Puigmal,Shiran Ferber,Santhosh Kalash Rajendrakumar,Michaela Prado,Alma L. Rodríguez,Walid S. Kamoun,Adnan O. Abu‐Yousif,Natalie Artzi
标识
DOI:10.1038/s41565-023-01447-7
摘要
Abstract Stimulator of interferon genes (STING) agonist is a promising activator of antitumor immunity. However, the systemic delivery of STING agonist, based on cyclic dinucleotides (CDNs), yields limited anticancer activity owing to poor serum stability and cellular internalization. Here, we show, in multiple models of murine cancer, that the intravenous administration of sub-microgram doses of chemically-modified CDNs covalently bound to poly(β-amino ester) nanoparticles (CDN-NP) results in potent innate and adaptive antitumor immune responses. The combination of CDN-NPs and immune checkpoint blockade led to largely curative outcomes, even after tumor re-challenge, in mouse models of melanoma and colon cancer and to survival benefit in a preclinical murine breast cancer model. The NPs activated STING signaling in immune cells in tumor and lymphoid tissues. We demonstrate, in a mouse melanoma model, that cancer-cell STING signaling is not necessary for therapeutic responses, but act as a nanoparticle reservoir, releasing CDN to proximal immune cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI